From: Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya
Test (n = 382) | Sensitivity | Specificity | PPV | NPV | AUROC (95% CI) | Youden’s index |
---|---|---|---|---|---|---|
Any TB symptom | 0 (0–52) | 87 (84–91) | 0 (0–7) | 99 (97–100) | 0.436 (0.419–0.453) | |
GeneXpert | 20 (1–72) | 99 (98–100) | 25 (1–81) | 99 (97–100) | 0.596 (0.400–0.792) | |
TST, induration | 0.629 (0.244–1.00) | |||||
≥ 5 mm | 50 (7–93) | 79 (74–83) | 3 (0–10) | 99 (97–100) | ||
≥ 10 mm | 50 (7–93) | 89 (85–92) | 5 (1–18) | 99 (98–100) | ||
CRP | 0.683 (0.355–1.00) | |||||
> 3.3 mg/L | 80 (28–100) | 72 (67–76) | 4 (1–9) | 100 (98–100) | 0.518 | |
> 5 mg/L | 40 (5–85) | 79 (75–83) | 3 (0.3–9) | 99 (97–100) | 0.193 | |
> 8 mg/L | 40 (5–85) | 89 (85–92) | 4 (1–15) | 99 (97–100) | 0.286 | |
> 10 mg/L | 20 (1–72) | 90 (86–93) | 3 (0–14) | 99 (97–100) | 0.099 | |
Hemoglobin | 0.352 (0.027–0.676) | |||||
< 8 g/dL | 0 (0–52) | 94 (91–96) | 0 (0–15) | 99 (97–100) | −0.064 | |
< 10 g/dL | 60 (15–95) | 86 (82–89) | 6 (1–16) | 99 (98–100) | 0.458 | |
< 15.3 g/dL | 80 (28–100) | 12 (9–16) | 1 (0–3) | 98 (88–100) | 0.082 | |
MLR (n = 362) | 0.449 (0.141–0.757) | |||||
> 0.208 | 40 (5–85) | 81 (76–85) | 3 (0–10) | 99 (97–100) | 0.207 | |
≥ 0.285 | 0 (0–52) | 94 (91–96) | 0 (0–16) | 99 (97–100) | −0.059 | |
NLR (n = 360) | 0.540 (0.200–0.879) | |||||
≥ 1.5 | 40 (5–85) | 80 (76–84) | 3 (0–10) | 99 (97–100) | 0.200 | |
ESR (n = 380) | 0.682 (0.436–0.927) | |||||
≥ 35.5 mm | 60 (15–95) | 78 (74–82) | 4 (1–10) | 99 (99–100) | 0.381 |